Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8869378rdf:typepubmed:Citationlld:pubmed
pubmed-article:8869378lifeskim:mentionsumls-concept:C1527169lld:lifeskim
pubmed-article:8869378lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:8869378lifeskim:mentionsumls-concept:C0376152lld:lifeskim
pubmed-article:8869378lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:8869378lifeskim:mentionsumls-concept:C0036576lld:lifeskim
pubmed-article:8869378lifeskim:mentionsumls-concept:C0376249lld:lifeskim
pubmed-article:8869378lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:8869378lifeskim:mentionsumls-concept:C1548978lld:lifeskim
pubmed-article:8869378lifeskim:mentionsumls-concept:C0445356lld:lifeskim
pubmed-article:8869378lifeskim:mentionsumls-concept:C1709634lld:lifeskim
pubmed-article:8869378pubmed:issue3lld:pubmed
pubmed-article:8869378pubmed:dateCreated1997-1-3lld:pubmed
pubmed-article:8869378pubmed:abstractTextA child with Sanfilippo syndrome and 5 potential unrelated marrow donors were typed serologically, tested in mixed lymphocyte reaction and typed by restriction fragment length polymorphism analysis in attempt to find a suitable donor. All donors were found to be identical with the recipient, however, these studies were not conclusive in identifying the best match donor. Therefore, recipient-donor pairs were examined by HLA-DR oligotyping. In addition we have studied the potential of cytotoxic T-lymphocytes precursors (CTL-p) analysis as a means of selection for matched unrelated donors. Low frequencies (1/10(5)) of pretransplant CTL-p correlated with oligotyping identity in all donor-recipient pairs evaluated. In one case oligotyping disclosed a previously unrecognized HLA-DRB1 disparity. This resulted in high frequencies of CTL-p (1/35,000). Based on this experience we can argue that CTL-p analysis may be used as an additional tool for selection of compatible unrelated marrow donors.lld:pubmed
pubmed-article:8869378pubmed:languageenglld:pubmed
pubmed-article:8869378pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8869378pubmed:citationSubsetIMlld:pubmed
pubmed-article:8869378pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8869378pubmed:statusMEDLINElld:pubmed
pubmed-article:8869378pubmed:monthSeplld:pubmed
pubmed-article:8869378pubmed:issn0031-0808lld:pubmed
pubmed-article:8869378pubmed:authorpubmed-author:MinieroRRlld:pubmed
pubmed-article:8869378pubmed:authorpubmed-author:MazzolaGGlld:pubmed
pubmed-article:8869378pubmed:authorpubmed-author:AmorosoAAlld:pubmed
pubmed-article:8869378pubmed:authorpubmed-author:BuscaAAlld:pubmed
pubmed-article:8869378pubmed:authorpubmed-author:MassaiaMMlld:pubmed
pubmed-article:8869378pubmed:authorpubmed-author:AttisanoCClld:pubmed
pubmed-article:8869378pubmed:authorpubmed-author:VassalloEElld:pubmed
pubmed-article:8869378pubmed:issnTypePrintlld:pubmed
pubmed-article:8869378pubmed:volume37lld:pubmed
pubmed-article:8869378pubmed:ownerNLMlld:pubmed
pubmed-article:8869378pubmed:authorsCompleteYlld:pubmed
pubmed-article:8869378pubmed:pagination168-70lld:pubmed
pubmed-article:8869378pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:meshHeadingpubmed-meshheading:8869378-...lld:pubmed
pubmed-article:8869378pubmed:year1995lld:pubmed
pubmed-article:8869378pubmed:articleTitleUsefulness of frequency analysis of cytotoxic T-lymphocytes precursors (CTL-p) for selection of HLA matched unrelated marrow donors.lld:pubmed
pubmed-article:8869378pubmed:affiliationDepartment of Pediatrics, University of Turin, Turin, Italy.lld:pubmed
pubmed-article:8869378pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8869378pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:8869378pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed